Evaluation of PhenoMATRIX and PhenoMATRIX PLUS for the screening of MRSA from nasal and inguinal/perineal swabs using chromogenic media
Journal of Clinical Microbiology · 2024
DOI: 10.1128/jcm.01152-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Microbiology, 2024. Verfasst von Abdessalam Cherkaoui und 2 weiteren Autor:innen. Beteiligte Einrichtung: Bacteriology Laboratory, Division of Laboratory Medicine, Department of Diagnostics, Geneva University Hospitals , Geneva, Switzerland. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The objective of this study was to assess the clinical performances of PhenoMATRIX and PhenoMATRIX PLUS for the screening of methicillin-resistant Staphylococcus aureus (MRSA) from nasal and inguinal/perineal ESwabs using chromogenic media. The automated performances were compared to the manual reading. Additionally, we evaluated PhenoMATRIX PLUS for the automatic release of the negative results to the Laboratory Information System (LIS) and the automatic discharge of the negative plates from the incubators. A total of 6,771 non-duplicate specimens were used by PhenoMATRIX as a machine learning model. The validation of these settings was performed on 17,223 non-duplicate specimens. The MRSA positivity rate was 5% (866/17,223). Validated settings were then used by PhenoMATRIX PLUS on another 1,409 non-duplicate specimens. The sensitivities of PhenoMATRIX and PhenoMATRIX PLUS were 99.8% [95% confidence interval (CI), 99.2%–99.9%] and 100% (95% CI, 92.1%–100%), respectively. The specificities of PhenoMATRIX and PhenoMATRIX PLUS were 99.1% (95% CI, 99.0%–99.2%) and 95.2% (95% CI, 93.8%–96.1%), respectively. All the 1,297 MRSA-negative specimens analyzed by PhenoMATRIX PLUS were automatically released and sent to the LIS immediately after availability of the culture image on the WASPLab (100% accuracy). All negative media plates were automatically discarded. PhenoMATRIX PLUS decreases the time spent by technologists on negative plates and ensures optimal usage of the incubators' capacity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bacteriology Laboratory, Division of Laboratory Medicine, Department of Diagnostics, Geneva University Hospitals , Geneva, Switzerland.
- Division of Infectious Diseases, Department of Medicine, Genomic Research Laboratory, Geneva University Hospitals and Faculty of Medicine , Geneva, Switzerland.
ORCID-Profile: Abdessalam Cherkaoui, Jacques Schrenzel
Zitieren
APA
Cherkaoui, A., Renzi, G., & Schrenzel, J. (2024). Evaluation of PhenoMATRIX and PhenoMATRIX PLUS for the screening of MRSA from nasal and inguinal/perineal swabs using chromogenic media. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.01152-23
Vancouver
Cherkaoui A, Renzi G, Schrenzel J. Evaluation of PhenoMATRIX and PhenoMATRIX PLUS for the screening of MRSA from nasal and inguinal/perineal swabs using chromogenic media. Journal of Clinical Microbiology. 2024. doi:10.1128/jcm.01152-23
BibTeX
@article{Cherkaoui2024,
author = {Cherkaoui, Abdessalam and Renzi, Gesuele and Schrenzel, Jacques},
title = {Evaluation of PhenoMATRIX and PhenoMATRIX PLUS for the screening of MRSA from nasal and inguinal/perineal swabs using chromogenic media},
journal = {Journal of Clinical Microbiology},
year = {2024},
doi = {10.1128/jcm.01152-23}
}
EUVIMED